| Surge Seen in Children Hospitalized With MRSA The number of children hospitalized with dangerous drug-resistant staph infections surged 10-fold in a recent nine-year period, a study found. Disease incidence increased from two cases to 21 cases per 1,000 hospital admissions from 1999 to 2008. Most infections were caught in the community, not in the hospital. online.wsj.com |
ERT to Announce Second Quarter 2010 Results on August 9, 2010 (PR Newswire) ERT announced today that it will release its results for the second quarter 2010 on Monday, August 9, 2010, after the market closes. After the release, the Company will host a conference call at 5:00 PM EDT that day. us.rd.yahoo.com |
Botox Sales Plump Up Allergan's Net Allergan's second-quarter earnings rose 36% as the company's sales jumped. Allergan, which makes the wrinkle treatment Botox, has seen continued increases in revenue. online.wsj.com |
Novartis Beats Merck in Race for Approval of First Oral MS Pill The Burrill Report submits: By Michael FitzhughGilenya has become the first oral multiple sclerosis pill capable of slowing the disease's progression and reducing relapses to win approval from the U.S. Food and Drug Administration. Novartis (NVS), developer of the drug, beat Merck's (MKGAY.PK) late-stage oral treatment cladribine to U.S. approval and could generate $1 billion in annual sales or more, according to both industry analysts and Novartis. Complete Story » seekingalpha.com |
Knee-Device Maker Slams FDA The maker of a knee-repair device said the government's recent move to bar its product was "totally unbelievable" and accused Food and Drug Administration officials of playing politics. online.wsj.com |